Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10941830rdf:typepubmed:Citationlld:pubmed
pubmed-article:10941830lifeskim:mentionsumls-concept:C0919453lld:lifeskim
pubmed-article:10941830lifeskim:mentionsumls-concept:C0020843lld:lifeskim
pubmed-article:10941830lifeskim:mentionsumls-concept:C0011155lld:lifeskim
pubmed-article:10941830lifeskim:mentionsumls-concept:C1420806lld:lifeskim
pubmed-article:10941830lifeskim:mentionsumls-concept:C0062821lld:lifeskim
pubmed-article:10941830lifeskim:mentionsumls-concept:C0018591lld:lifeskim
pubmed-article:10941830lifeskim:mentionsumls-concept:C0206243lld:lifeskim
pubmed-article:10941830lifeskim:mentionsumls-concept:C0231449lld:lifeskim
pubmed-article:10941830pubmed:issue3lld:pubmed
pubmed-article:10941830pubmed:dateCreated2000-11-21lld:pubmed
pubmed-article:10941830pubmed:abstractTextWe showed previously that the conserved extended MHC haplotype [HLA-B8, SCO1, DR3] carries recessive susceptibility genes for IgA and IgG4 deficiency and dominant genes for IgD and IgG3 deficiency. [HLA-B18, F1C30, DR3] has similar class II and III regions to [HLA-B8, SC01, DR3] and is common in the Basques. We therefore studied serum immunoglobulin concentrations in Basque homozygotes, heterozygotes, and noncarriers of (FIC30, DRB1*0301, DRB3*02, DQA1*0501. DQB1*0201) (F1C30, DR3). As shown by others, no subjects were deficient in IgA, IgM, or IgG subclasses. In contrast, 29% of homozygotes and three of seven double heterozygotes with (SC01, DRB1*0301, DRB3*0101, DQA1*0501, DQB1*0201) (presumed homozygotes for IgD deficiency susceptibility genes) were IgD deficient. Thus, 32% of presumed homozygotes were IgD deficient compared with 1.6% of noncarriers. Of haplotype heterozygotes, 25% were IgD deficient. The high frequency of IgD deficiency in both homozygotes and heterozygotes for (F1C30, DR3) suggests a partially penetrant dominant susceptibility gene for IgD deficiency on [HLA-B18, F1C30, DR3].lld:pubmed
pubmed-article:10941830pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10941830pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10941830pubmed:languageenglld:pubmed
pubmed-article:10941830pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10941830pubmed:citationSubsetIMlld:pubmed
pubmed-article:10941830pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10941830pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10941830pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10941830pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10941830pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10941830pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10941830pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10941830pubmed:statusMEDLINElld:pubmed
pubmed-article:10941830pubmed:monthMaylld:pubmed
pubmed-article:10941830pubmed:issn0271-9142lld:pubmed
pubmed-article:10941830pubmed:authorpubmed-author:AlperC ACAlld:pubmed
pubmed-article:10941830pubmed:authorpubmed-author:CalvoBBlld:pubmed
pubmed-article:10941830pubmed:authorpubmed-author:AwdehZZlld:pubmed
pubmed-article:10941830pubmed:authorpubmed-author:Marcus-Bagley...lld:pubmed
pubmed-article:10941830pubmed:authorpubmed-author:CastañoLLlld:pubmed
pubmed-article:10941830pubmed:authorpubmed-author:FiciD ADAlld:pubmed
pubmed-article:10941830pubmed:issnTypePrintlld:pubmed
pubmed-article:10941830pubmed:volume20lld:pubmed
pubmed-article:10941830pubmed:ownerNLMlld:pubmed
pubmed-article:10941830pubmed:authorsCompleteYlld:pubmed
pubmed-article:10941830pubmed:pagination216-20lld:pubmed
pubmed-article:10941830pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:10941830pubmed:meshHeadingpubmed-meshheading:10941830...lld:pubmed
pubmed-article:10941830pubmed:meshHeadingpubmed-meshheading:10941830...lld:pubmed
pubmed-article:10941830pubmed:meshHeadingpubmed-meshheading:10941830...lld:pubmed
pubmed-article:10941830pubmed:meshHeadingpubmed-meshheading:10941830...lld:pubmed
pubmed-article:10941830pubmed:meshHeadingpubmed-meshheading:10941830...lld:pubmed
pubmed-article:10941830pubmed:meshHeadingpubmed-meshheading:10941830...lld:pubmed
pubmed-article:10941830pubmed:meshHeadingpubmed-meshheading:10941830...lld:pubmed
pubmed-article:10941830pubmed:meshHeadingpubmed-meshheading:10941830...lld:pubmed
pubmed-article:10941830pubmed:meshHeadingpubmed-meshheading:10941830...lld:pubmed
pubmed-article:10941830pubmed:meshHeadingpubmed-meshheading:10941830...lld:pubmed
pubmed-article:10941830pubmed:meshHeadingpubmed-meshheading:10941830...lld:pubmed
pubmed-article:10941830pubmed:meshHeadingpubmed-meshheading:10941830...lld:pubmed
pubmed-article:10941830pubmed:meshHeadingpubmed-meshheading:10941830...lld:pubmed
pubmed-article:10941830pubmed:meshHeadingpubmed-meshheading:10941830...lld:pubmed
pubmed-article:10941830pubmed:meshHeadingpubmed-meshheading:10941830...lld:pubmed
pubmed-article:10941830pubmed:meshHeadingpubmed-meshheading:10941830...lld:pubmed
pubmed-article:10941830pubmed:year2000lld:pubmed
pubmed-article:10941830pubmed:articleTitleThe [HLA-B18, F1C30, DR3] conserved extended haplotype carries a susceptibility gene for IgD deficiency.lld:pubmed
pubmed-article:10941830pubmed:affiliationThe Center for Blood Research, Harvard Medical School, Boston, Massachusetts 02115, USA.lld:pubmed
pubmed-article:10941830pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10941830pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:10941830pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10941830lld:pubmed